O Conlon1, K McKinney. 1. Dept of Obstetrics and Gynaecology Daisy Hill Hospital, Newry. orla.conlon@btinternet.com
Abstract
BACKGROUND: In recent years, medical controversy, has surrounded the prescribing of hormone replacement therapy (HRT). AIM: This study aimed to establish whether prescribing of HRT in Northern Ireland has changed and what the current prescribing patterns are. METHOD: A structured questionnaire was sent by post to all medical staff in Obstetrics and Gynaecology in Northern Ireland. A stamped addressed envelope was included. RESULTS: Overall 54% of respondents indicated that they had changed their prescribing practice on HRT in the past year. The primary indication for prescribing HRT was vasomotor symptoms (93%). Fifty-six per cent of doctors recommended 1-5 years as duration of use. Oral preparations were those most commonly prescribed (57%). The dose and type chosen were the same whether prescribing had changed or not. CONCLUSIONS: More than half of all doctors who responded had changed their prescribing practices on HRT, yet some respondents still preferred more traditional prescribing.
BACKGROUND: In recent years, medical controversy, has surrounded the prescribing of hormone replacement therapy (HRT). AIM: This study aimed to establish whether prescribing of HRT in Northern Ireland has changed and what the current prescribing patterns are. METHOD: A structured questionnaire was sent by post to all medical staff in Obstetrics and Gynaecology in Northern Ireland. A stamped addressed envelope was included. RESULTS: Overall 54% of respondents indicated that they had changed their prescribing practice on HRT in the past year. The primary indication for prescribing HRT was vasomotor symptoms (93%). Fifty-six per cent of doctors recommended 1-5 years as duration of use. Oral preparations were those most commonly prescribed (57%). The dose and type chosen were the same whether prescribing had changed or not. CONCLUSIONS: More than half of all doctors who responded had changed their prescribing practices on HRT, yet some respondents still preferred more traditional prescribing.
Authors: Eva Lundström; Alexander Christow; Wendy Kersemaekers; Gunilla Svane; Edward Azavedo; Gunnar Söderqvist; Mirjam Mol-Arts; Jan Barkfeldt; Bo von Schoultz Journal: Am J Obstet Gynecol Date: 2002-04 Impact factor: 8.661
Authors: B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings Journal: JAMA Date: 1999-08-18 Impact factor: 56.272
Authors: Jane A Cauley; John Robbins; Zhao Chen; Steven R Cummings; Rebecca D Jackson; Andrea Z LaCroix; Meryl LeBoff; Cora E Lewis; Joan McGowan; Joan Neuner; Mary Pettinger; Marcia L Stefanick; Jean Wactawski-Wende; Nelson B Watts Journal: JAMA Date: 2003-10-01 Impact factor: 56.272
Authors: Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene Journal: JAMA Date: 2002-07-17 Impact factor: 56.272